Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities | Synapse
March 3, 2026
Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities
HZ
HUIPING ZHOU
Virginia Commonwealth University
YH
Yi Huang
CC
Chen Chen
Beijing Institute of Technology
Ver todo
Puntos clave
Bile acid metabolism is significantly altered in liver disease, impacting overall health.
The analysis reveals that therapeutic opportunities exist for targeting gut microbiome interactions within liver disease.
This study uses observational data to explore mechanisms linking the gut microbiome to liver disease progression.
These findings suggest potential therapeutic strategies may enhance liver health, yet more clinical validation is needed.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
ZHOU et al. (Fri,) studied this question.
synapsesocial.com/papers/69a75ea4c6e9836116a29748
https://doi.org/https://doi.org/10.1016/j.pharmr.2026.100120